Literature DB >> 27101818

Danger Signals and Inflammation.

Theoharis C Theoharides1.   

Abstract

Mesh：

Year:  2016        PMID： 27101818     DOI： 10.1016/j.clinthera.2016.03.036

Source DB:  PubMed          Journal:  Clin Ther        ISSN： 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  6 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

2.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

Review 3.  IL-1 Superfamily Members and Periodontal Diseases.

Authors:  E Papathanasiou; P Conti; F Carinci; D Lauritano; T C Theoharides
Journal:  J Dent Res       Date:  2020-08-06       Impact factor: 6.116

4.  A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis.

Authors:  Pinelopi Samara; Vivi Miriagou; Michael Zachariadis; Olga Mavrofrydi; Vasilis J Promponas; Skarlatos G Dedos; Panagiota Papazafiri; Hubert Kalbacher; Wolfgang Voelter; Ourania Tsitsilonis
Journal:  Oncotarget       Date:  2017-07-25

5.  Stress, Inflammation, and Autoimmunity: The 3 Modern Erinyes.

Authors:  Theoharis C Theoharides
Journal:  Clin Ther       Date:  2020-04-18       Impact factor: 3.393

6.  Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes.

Authors:  Evelyn Kelemen; Éva Ádám; Stella Márta Sági; Anikó Göblös; Lajos Kemény; Zsuzsanna Bata-Csörgő; Márta Széll; Judit Danis
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.